Research Engineer, Immunotherapy & mRNA Cancer Vaccines
Oslo universitetssykehus HF
Eine vollständige Bewerbung in einer Minute
Maßgeschneiderter Lebenslauf und Anschreiben – versandbereit.
Benefits dieser Stelle
Zusammenfassung
Oslo University Hospital invites applications for a research engineer in molecular and cell biology within the targeted therapies and immunomodulation group. The role centers on designing and conducting in vitro and in vivo experiments to identify receptors and enhance mRNA cancer vaccines.
You will collaborate with a group leader to publish findings and contribute to translational research bridging lab discoveries to cancer immunotherapy within a productive, welfare-focused environment at
Qualifikationen
- Master's degree in molecular biology, cell biology, biotechnology, immunology, or a related field.
- Practical experience in molecular and cellular biology, including cell culture, transfection, cloning, and protein analysis.
- Experience with flow cytometry, immunoprecipitation, tagged protein purification, or immunological techniques is highly desirable.
- Good communication skills in English.
Aufgaben
- Design and conduct a range of in vitro and in vivo experiments to identify cell-surface receptors involved in antibody binding to cancer cells.
- Analyze experimental data and contribute to scientific publications.
- Aim to enhance efficacy of mRNA-based cancer vaccines through mRNA modifications.
Kenntnisse
Ausbildung
Tools
Jobbeschreibung
Oslo University Hospital invites applications for a research engineer in molecular and cell biology within the targeted therapies and immunomodulation group. The role centers on designing and conducting in vitro and in vivo experiments to identify receptors and enhance mRNA cancer vaccines.
You will collaborate with a group leader to publish findings and contribute to translational research bridging lab discoveries to cancer immunotherapy within a productive, welfare-focused environment at
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
